Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Pentavalent methylated arsenicals are substrates of human AQP9.

McDermott JR, Jiang X, Beene LC, Rosen BP, Liu Z.

Biometals. 2010 Feb;23(1):119-27. doi: 10.1007/s10534-009-9273-9. Epub 2009 Oct 4.

2.

Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia.

Kiguchi T, Yoshino Y, Yuan B, Yoshizawa S, Kitahara T, Akahane D, Gotoh M, Kaise T, Toyoda H, Ohyashiki K.

Leuk Res. 2010 Mar;34(3):403-5. doi: 10.1016/j.leukres.2009.08.001. Epub 2009 Sep 4.

PMID:
19733394
3.

Vitamin E protects against the mitochondrial damage caused by cyclosporin A in LLC-PK1 cells.

de Arriba G, de Hornedo JP, Rubio SR, Fernández MC, Martínez SB, Camarero MM, Cid TP.

Toxicol Appl Pharmacol. 2009 Sep 15;239(3):241-50. doi: 10.1016/j.taap.2009.05.028. Epub 2009 Jun 11.

PMID:
19523970
4.

Arsenic induces telomerase expression and maintains telomere length in human cord blood cells.

Ferrario D, Collotta A, Carfi M, Bowe G, Vahter M, Hartung T, Gribaldo L.

Toxicology. 2009 Jun 16;260(1-3):132-41. doi: 10.1016/j.tox.2009.03.019. Epub 2009 Apr 9.

PMID:
19464579
5.

Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

Matsson P, Pedersen JM, Norinder U, Bergström CA, Artursson P.

Pharm Res. 2009 Aug;26(8):1816-31. doi: 10.1007/s11095-009-9896-0. Epub 2009 May 7.

PMID:
19421845
6.

Role of aquaporin 9 in cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes.

Shinkai Y, Sumi D, Toyama T, Kaji T, Kumagai Y.

Toxicol Appl Pharmacol. 2009 Jun 1;237(2):232-6. doi: 10.1016/j.taap.2009.03.014. Epub 2009 Mar 31.

PMID:
19341753
7.

Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia.

Yoshino Y, Yuan B, Miyashita SI, Iriyama N, Horikoshi A, Shikino O, Toyoda H, Kaise T.

Anal Bioanal Chem. 2009 Jan;393(2):689-97. doi: 10.1007/s00216-008-2487-9. Epub 2008 Nov 14.

PMID:
19009285
8.

Direct contribution of inducible nitric oxide synthase expression to apoptosis induction in primary smooth chorion trophoblast cells of human fetal membrane tissues.

Yuan B, Ohyama K, Takeichi M, Toyoda H.

Int J Biochem Cell Biol. 2009 May;41(5):1062-9. doi: 10.1016/j.biocel.2008.09.031. Epub 2008 Oct 17.

PMID:
18984062
9.

Effects of cyclosporine on the production of the reactive oxygen species in the glial cells.

Mun KC, Lee KT, Choi HJ, Jin KB, Han SY, Park SB, Kim HC, Ha EY, Kim YH.

Transplant Proc. 2008 Oct;40(8):2742-3. doi: 10.1016/j.transproceed.2008.08.007.

PMID:
18929851
10.

Arsenic trioxide.

Litzow MR.

Expert Opin Pharmacother. 2008 Jul;9(10):1773-85. doi: 10.1517/14656566.9.10.1773 . Review.

PMID:
18570609
11.

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia.

Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4826-31. doi: 10.1073/pnas.0712365105. Epub 2008 Mar 14.

12.

Acute promyelocytic leukemia: from highly fatal to highly curable.

Wang ZY, Chen Z.

Blood. 2008 Mar 1;111(5):2505-15. doi: 10.1182/blood-2007-07-102798. Review.

13.

Imbalance between ROS production and elimination results in apoptosis induction in primary smooth chorion trophoblast cells prepared from human fetal membrane tissues.

Yuan B, Ohyama K, Bessho T, Uchide N, Toyoda H.

Life Sci. 2008 Mar 12;82(11-12):623-30. doi: 10.1016/j.lfs.2007.12.016. Epub 2007 Dec 28.

PMID:
18234233
14.

Arsenical-based cancer drugs.

Dilda PJ, Hogg PJ.

Cancer Treat Rev. 2007 Oct;33(6):542-64. Epub 2007 Jul 10. Review.

PMID:
17624680
15.

Increased oxidative DNA products in patients with acute promyelocytic leukemia during arsenic therapy.

Ninomiya M, Kajiguchi T, Yamamoto K, Kinoshita T, Emi N, Naoe T.

Haematologica. 2006 Nov;91(11):1571-2.

16.

Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid.

Liu Z, Sanchez MA, Jiang X, Boles E, Landfear SM, Rosen BP.

Biochem Biophys Res Commun. 2006 Dec 15;351(2):424-30. Epub 2006 Oct 17.

17.

Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.

Leung J, Pang A, Yuen WH, Kwong YL, Tse EW.

Blood. 2007 Jan 15;109(2):740-6. Epub 2006 Sep 12.

18.

Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.

Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, Hashimoto H, Kinoshita K, Shimoya M, Kaise T, Ohnishi K.

Cancer Chemother Pharmacol. 2007 Mar;59(4):485-93. Epub 2006 Aug 26.

PMID:
16937107
19.

Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line.

Lee TC, Ho IC, Lu WJ, Huang JD.

J Biol Chem. 2006 Jul 7;281(27):18401-7. Epub 2006 May 3. Erratum in: J Biol Chem. 2007 Apr 13;282(15):11612.

20.

Contribution of inducible nitric oxide synthase and cyclooxygenase-2 to apoptosis induction in smooth chorion trophoblast cells of human fetal membrane tissues.

Yuan B, Ohyama K, Bessho T, Toyoda H.

Biochem Biophys Res Commun. 2006 Mar 17;341(3):822-7. Epub 2006 Jan 23.

PMID:
16442500
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk